The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 2, 2007, Pages 469-474

  Ohara, Koichi ^a  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

Author keywords

D2 receptor; Docosahexanoic acid; Dopamine hypothesis; Eicosapentanoic acid; n 3 fatty acid; Schizophrenia

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

ARTICLE; COGNITIVE DEFECT; DOPAMINERGIC SYSTEM; ERYTHROCYTE MEMBRANE; ESSENTIAL FATTY ACID DEFICIENCY; FAT INTAKE; HUMAN; LIMBIC SYSTEM; NEGATIVE SYNDROME; NERVE ENDING; PREFRONTAL CORTEX; SCHIZOPHRENIA;

DOPAMINE; FATTY ACIDS, OMEGA-3; HUMANS; MODELS, BIOLOGICAL; SCHIZOPHRENIA;

EID: 33846781334     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.11.013     Document Type: Article

References (49)

1. Abi-Dargham A. Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol 7 Suppl 1 (2004) S1-S5
2. Aïd S., Vancassel S., Poumès-Ballihaut C., Chalon S., Guesnet P., and Lavialle M. Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus. J Lipid Res 44 (2003) 1545-1551
3. Arvindakshan M., Ghate M., Ranjekar P.K., Evans D.R., and Mahadik S.P. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr Res 62 (2003) 195-204
4. Arvindakshan M., Sitasawad S., Debsikdar V., Ghate M., Evans D., Horrobin D.F., et al. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biol Psychiatry 53 (2003) 56-64
5. Chalon S., Delion-Vancassel S., Belzung C., Guilloteau D., Leguisquet A.-M., Besnard J.-C., et al. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J Nutr 128 (1998) 2512-2519
6. Chalon S., Vancassel S., Guilloteau D., and Durand G. Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission. Lipids 36 (2001) 937-944
7. Civelli O., Bunzow J.R., Grandy D.K., Zhou Q.Y., and Van Tol H.H. Molecular biology of the dopamine receptors. Eur J Pharmacol 207 (1991) 277-286
8. Davis K.L., Kahn R.S., Ko G., and Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148 (1991) 1474-1486
9. Delion S., Chalon S., Hérault J., Guilloteau D., Besnard J.-C., and Durand G. Chronic dietary α-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J Nutr 124 (1994) 2466-2476
10. Delion S., Chalon S., Guilloteau D., Besnard J.-C., and Durand G. α-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J Neurochem 66 (1996) 1582-1591
11. Deutch A.Y. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J Neural Transm Suppl 36 (1992) 61-89
12. Deutsch A.Y., and Cameron D.S. Pharmacological characterization of dopamine systems in nucleus accumbens core and shell. Neurosci 46 (1992) 49-56
13. de la Presa Owens S., and Innis S.M. Docosahexanoic and arachidonic acid prevent a decrease in dopaminergic neurotransmitters in frontal cortex caused by a linoleic and α-linolenic acid deficient diet in formula-fed piglets. J Nutr 129 (1999) 2088-2093
14. du Bois T.M., Bell W., Deng C., and Huang X.-F. A high n-6 polyunsaturated fatty acids diet reduces muscarinic M2/M4 receptor binding in the rat brain. J Chem Neuroanat 29 (2005) 282-288
15. du Bois T.M., Deng C., and Huang X.F. Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia. Prog Neuro Psychopharmacol Biol Psychiatry 29 (2005) 878-888
16. du Bois T.M., Deng C., Bell W., and Huang X.-F. Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain. Neuroscience 139 (2006) 1397-1403
17. Emsley R., Myburgh C., Oosthuizen P., and van Rensburg S.J. Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Am J Psychiatry 159 (2002) 1596-1598
18. Fenton W.S., Dickerson F., Boronow J., Hibbeln J.R., and Knable M. A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry 158 (2001) 2071-2074
19. Gattaz W.F., Köllisch M., Thuren T., Virtanen J.A., and Kinnunen P.K.J. Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy. Biol Psychiatry 22 (1987) 421-426
20. Gattaz W.F., Schmitt A., and Maras A. Increased platelet phospholipase A2 activity in schizophrenia. Schizophr Res 16 (1995) 1-6
21. Glen A.I., Glen E.M., Horrobin D.F., Vaddadi K.S., Spellman M., Morse-Fisher N., et al. A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophr Res 12 (1994) 53-61
22. Glowinski J., Tassin J.P., and Thierru A.M. The mesocortical-prefrontal dopaminergic neurons. Trends Neurosci 7 (1984) 415-418
23. Haroutunian V., Knott P., and Davis K.L. Effects of mesocortical dopaminergic lesions upon subcortical dopaminergic function. Psychopharmacol Bull 24 (1988) 341-344
24. Horrobin D.F. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 30 (1998) 193-208
25. Horrobin D.F., Glen A.I.M., and Vaddadi K. The membrane hypothesis of schizophrenia. Schizophr Res 13 (1994) 195-207
26. King D., and Finlay J.M. Effects of selective dopamine depletion in medial prefrontal cortex on basal and evoked extracellular dopamine in neostriatum. Brain Res 685 (1995) 117-128
27. King D., Zigmond M.J., and Finlay J.M. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience 77 (1997) 141-153
28. Kitajka K., Sinclair A.J., Weisinger R.S., Weisinger H.S., Mathai M., Jayasooriya A.P., et al. Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc Natl Acad Sci U S A 101 (2004) 10931-10936
29. Kodas E., Page G., Zimmer L., Vancassel S., Guilloteau D., Durand G., et al. Neither the density nor function of striatal dopamine transporters were influenced by chronic n-3 polyunsaturated fatty acid deficiency in rodents. Neurosci Lett 21 (2002) 95-99
30. Leccesse A.P., and Lyness W.H. Lesions of dopamine neurons in the medial prefrontal cortex: effects on self-administration of amphetamine and dopamine synthesis in the brain of the rat. Neuropharmacology 26 (1987) 1303-1308
31. Le Moal M., and Simon R. Mesocorticolimbic dopaminergic networks: functional and regulatory roles. Physiol Rev 71 (1991) 155-234
32. Mathé J.M., Nomikos G.G., Blakeman K.H., and Svensson T.H. Differential actions of dizocipine (MK-801) on the mesolimbic and mesocortical dopamine systems: role of neuronal activity. Neuropharmacology 38 (1999) 121-128
33. Mellor J.E., Laugharne J.D., and Peet M. Schizophrenic symptoms and dietary intake of n-3 fatty acids. Schizophr Res 18 (1995) 85-86
34. Neuringer M., Anderson G.J., and Connor W.E. The essentiality of n-3 fatty acids for the development and function of the retina and brain. Annu Rev Nutr 8 (1988) 517-541
35. Ohara K. Schizophrenia in essential fatty acid. Clin. Psychiatry 34 (2005) 1427-1433 [in Japanese]
36. Peet M., and Edwards R.W. Lipids, depression and physical diseases. Curr Opin Psychiatry 10 (1997) 477-480
37. Peet M., and Horrobin D.F. E-E muticentre study group. A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatr Res 36 (2002) 7-18
38. Peet M., Laugharne J., Rangarajan N., Horrobin D., and Reynolds G. Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients. J Psychiatr Res 29 (1995) 227-232
39. Pycock C.J., Kerwin R.W., and Carter C.J. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286 (1980) 74-76
40. Salamone J.D., Cousins M.S., McCullough L.D., Carriero D.L., and Berkowitz R.J. Nucleus accumbens dopamine release increases during instrumental lever pressing for food but not free food consumption. Pharmacol Biochem Behav 49 (1994) 25-31
41. Scatton B., Worms P., Lloyd K.G., and Bartholini G. Cortical modulation of striatal function. Brain Res 232 (1982) 331-343
42. Stahl S.M. Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 2nd Ed (2000), Cambridge University Press
43. Suzuki H., Park S.J., Tamura M., and Ando S. Effect of the long-term feeding of dietary lipids on the learning ability, fatty acid composition of brain stem phospholipids and synaptic membrane fluidity in adult mice: a comparison of sardine oil diet with palm oil diet. Mech Ageing Dev 101 (1998) 119-128
44. Vallone D., Picetti R., and Borrelli E. Structure and function of dopamine receptors. Neurosci Biobehav Rev 24 (2000) 125-132
45. Yoshida S., Yasuda A., Kawazato H., Sakai K., Shimada T., Takeshita M., et al. Synaptic vesicle ultrastructural changes in the rat hippocampus induced by a combination of alpha-linolenate deficiency and a learning task. J Neurochem 68 (1997) 1261-1268
46. Zimmer L., Hembert S., Durand G., Breton P., Guilloteau D., Besnard J.C., et al. Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study. Neurosci Lett 240 (1998) 177-181
47. Zimmer L., Delion-Vancassel S., Durand G., Guilloteau D., Bodard S., Besnard J.-C., et al. Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 41 (2000) 32-40
48. Zimmer L., Delpal S., Guilloteau D., Aioun J., Durand G., and Chalon S. Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neurosci Lett 284 (2000) 25-28
49. Zimmer L., Vancassel S., Cantagrel S., Breton P., Delamanche S., Guilloteau D., et al. The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. Am J Clin Nutr 75 (2002) 662-667